Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-05-30CS-8958 - A Phase I, Double-blind, Placebo-controlled, Ascending, Multiple Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2018-05-03Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H3N2v (6-2) AA ca Recombinant (A/Minnesota/11/2010 (H3N2v) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H3N2v Disease
-
CLINICAL_TRIALS study record update · 2018-04-18High Dose Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes - A Pilot Evaluation
-
CLINICAL_TRIALS study record update · 2018-04-11Indian Herbal Medicine for Influenza - Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2018-04-06Two-site Intradermal Influenza Vaccination in Elderly
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-04-04A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
-
CLINICAL_TRIALS study record update · 2018-04-03Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
-
CLINICAL_TRIALS study record update · 2018-03-30Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
-
CLINICAL_TRIALS study record update · 2018-03-29A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza
-
CLINICAL_TRIALS study record update · 2018-03-20Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
-
CLINICAL_TRIALS study record update · 2018-03-16An Open-label, Multi-centre, Randomised, Comparative Study of the Immunogenicity and Safety of an Inactivated Split-Virion Influenza Vaccine Administered by Intradermal Route (Flu-ID 15μg) Versus an Inactivated Adjuvanted Influenza Vaccine Administered by Intramuscular Route in Subjects 65 Years of Age or Older
-
CLINICAL_TRIALS study record update · 2018-03-08A Double-blind, Randomized, Placebo-controlled Study of the Safety,Tolerability and Pharmacokinetics of Increasing Doses of XC221 After Single and Repeated Oral Administration in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2018-03-05Safety and Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2340272A in Adults Aged 18 to 60 Years
-
CLINICAL_TRIALS study record update · 2018-03-01Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India
-
CLINICAL_TRIALS study record update · 2018-02-26A Phase II, Open, Controlled Study to Evaluate the Reactogenicity and the Immunogenicity of GlaxoSmithKline Biologicals' Adjuvanted Influenza Vaccine in Elderly Adults Previously Vaccinated With Either Fluarix™ or the Adjuvanted Vaccine.
-
CLINICAL_TRIALS study record update · 2018-02-23Clinical Study to Assess Efficacy, Safety, Tolerability and Optimal Dose Ranging of XC8 in Doses 20, 100 and 200 mg Once Daily in Patients With Uncomplicated Influenza or Other Acute Respiratory Viral Infections (ARVI)
-
CLINICAL_TRIALS study record update · 2018-02-23ClinicalTrials.gov study NCT03004040
-
CLINICAL_TRIALS study record update · 2018-02-19Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (GSK2340272A) in Children Aged 3 to 17 Years
-
CLINICAL_TRIALS study record update · 2018-02-09Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
-
CLINICAL_TRIALS study record update · 2018-02-09A Multicenter, Randomized, Double-blind, Active-controlled Phase 2b Trial [Part of EU-funded UNISEC Project] to Assess the Immunogenicity & Safety of a BiondVax's Influenza Vaccine (M-001) Followed by H5N1 Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2018-02-06Clinical Performance of the Diassess Influenza A and B Test
-
CLINICAL_TRIALS study record update · 2018-02-01A Prospective Multi-Centre Study of the Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.
-
CLINICAL_TRIALS study record update · 2018-01-30Surveillance of Nosocomial Influenza at Edouard Herriot University Hospital, Lyon, France.
-
CLINICAL_TRIALS study record update · 2018-01-16Post-Authorization Safety Study (PASS) of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK2340272A) in the United Kingdom (UK)
-
CLINICAL_TRIALS study record update · 2018-01-08Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations